• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较消化不良患者来源的幽门螺杆菌菌株中新的和经典的与克拉霉素耐药相关的点突变及其对表型克拉霉素耐药的影响。

Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.

机构信息

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Beykent University Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

出版信息

J Med Microbiol. 2019 Apr;68(4):566-573. doi: 10.1099/jmm.0.000944. Epub 2019 Feb 6.

DOI:10.1099/jmm.0.000944
PMID:30724729
Abstract

PURPOSE

We aimed to investigate the presence of three recently identified point mutations (A2115G, G2141A and A2144T) of the 23 S rRNA gene and compare them with the three most frequently encountered point mutations (A2142G, A2142C and A2143G) in Helicobacter pylori strains in Turkey.

METHODOLOGY

A total of 63 patients (mean 47.08±12.27) were included. The E-test method (for clarithromycin) was used for the clarithromycin antimicrobial susceptibility test of isolated H. pylori strains. Real-time PCR was used to detect the point mutations.

RESULTS

A total of 24 out of 63 H. pylori strains (38.1%) were detected as clarithromycin resistant (>0.5 mg l ). The new A2115G (n:6, 25%), A2144T (n:7, 29.1%) and G2141A, 8 (n:8, 33.3%) mutations and the classical A2142G (n:8, 33.3%) and A2143G (n:11, 45.8%) point mutations were detected in the 24 clarithromycin-resistant strains. The A2144T point mutation had the highest median MIC value (3 mg l ) amongst the new mutations, but the classical mutations (A2142G and A2143G) had the highest median MIC values (256 mg l ) overall. The presence of the A2115G (OR:31.66), A2144T (OR:36.92) or G2141A (OR:28.16) mutations increased the likelihood of clarithromycin resistance in H. pylori strains by 31.66-, 36.92- and 28.16-fold (ORs), respectively, according to the binary logistic regression analysis.

CONCLUSION

We concluded that classical mutations of the 23 S rRNA gene resulted in higher clarithromycin MIC values than new mutations. These new point mutations caused moderate elevations in the MIC values of clarithromycin-resistant H. pylori strains.

摘要

目的

我们旨在研究 23S rRNA 基因中最近发现的三个点突变(A2115G、G2141A 和 A2144T)的存在,并将其与土耳其幽门螺杆菌菌株中最常见的三个点突变(A2142G、A2142C 和 A2143G)进行比较。

方法

共纳入 63 例患者(平均年龄 47.08±12.27 岁)。采用 E 试验法(克拉霉素)对分离的幽门螺杆菌菌株进行克拉霉素抗菌药敏试验。采用实时 PCR 检测点突变。

结果

63 株幽门螺杆菌菌株中,共有 24 株(38.1%)被检测为克拉霉素耐药(>0.5mg/ml)。在 24 株克拉霉素耐药菌株中,检测到新的 A2115G(n:6,25%)、A2144T(n:7,29.1%)和 G2141A(n:8,33.3%)突变以及经典的 A2142G(n:8,33.3%)和 A2143G(n:11,45.8%)点突变。新突变中 A2144T 点突变的中位 MIC 值最高(3mg/ml),但经典突变(A2142G 和 A2143G)的中位 MIC 值总体最高(256mg/ml)。二元逻辑回归分析显示,A2115G(OR:31.66)、A2144T(OR:36.92)或 G2141A(OR:28.16)突变的存在使幽门螺杆菌菌株对克拉霉素耐药的可能性分别增加 31.66 倍、36.92 倍和 28.16 倍。

结论

我们得出结论,23S rRNA 基因的经典突变导致克拉霉素 MIC 值升高,而新突变导致克拉霉素耐药的幽门螺杆菌菌株 MIC 值中度升高。

相似文献

1
Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.比较消化不良患者来源的幽门螺杆菌菌株中新的和经典的与克拉霉素耐药相关的点突变及其对表型克拉霉素耐药的影响。
J Med Microbiol. 2019 Apr;68(4):566-573. doi: 10.1099/jmm.0.000944. Epub 2019 Feb 6.
2
PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains.PCR-RFLP检测幽门螺杆菌菌株中23S rRNA基因导致对克拉霉素耐药的点突变A2143G和A2142G
Acta Biochim Pol. 2014;61(2):311-5. Epub 2014 Jun 13.
3
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy.意大利幽门螺杆菌 rRNA 点突变与克拉霉素耐药性的变化。
J Med Microbiol. 2014 Mar;63(Pt 3):453-457. doi: 10.1099/jmm.0.067942-0. Epub 2013 Dec 16.
4
Antimicrobial resistance pattern of Helicobacter pylori in patients evaluated for dyspeptic symptoms in North-Eastern India with focus on detection of clarithromycin resistance conferring point mutations A2143G and A2142G within bacterial 23S rRNA gene.在印度东北部,针对消化不良症状评估的患者中幽门螺杆菌的抗生素耐药模式,重点检测细菌 23S rRNA 基因中导致克拉霉素耐药的点突变 A2143G 和 A2142G。
Indian J Med Microbiol. 2024 Jul-Aug;50:100652. doi: 10.1016/j.ijmmb.2024.100652. Epub 2024 Jul 2.
5
High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates.伊朗幽门螺杆菌临床分离株中与克拉霉素耐药相关的A2142G点突变率较高。
APMIS. 2016 Sep;124(9):787-93. doi: 10.1111/apm.12567. Epub 2016 Jun 30.
6
Mutations in the Helicobacter pylori 23S rRNA gene associated with clarithromycin resistance in patients at an endoscopy unit in Medellín, Colombia.哥伦比亚麦德林一家内镜检查单位中,幽门螺杆菌23S rRNA基因的突变与患者对克拉霉素的耐药性相关。
Biomedica. 2019 Aug 1;39(Supl. 2):117-129. doi: 10.7705/biomedica.v39i4.4377.
7
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.幽门螺杆菌基因型和抗生素耐药模式与人及狗相关,与克拉霉素耐药的 A2142G 和 A2143G 点突变有关。
Microb Pathog. 2018 Oct;123:330-338. doi: 10.1016/j.micpath.2018.07.016. Epub 2018 Jul 18.
8
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.通过用于检测23S rRNA基因突变的PCR线探针检测法准确预测幽门螺杆菌对大环内酯类药物的耐药性:多中心验证研究
Antimicrob Agents Chemother. 2001 May;45(5):1500-4. doi: 10.1128/AAC.45.5.1500-1504.2001.
9
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt.埃及开罗幽门螺杆菌23S rRNA基因V结构域的突变
J Chemother. 2016 Oct;28(5):367-70. doi: 10.1179/1973947815Y.0000000067. Epub 2016 Jun 28.
10
Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients.在苏丹患者中检测到与克拉霉素耐药相关的幽门螺杆菌 23S rRNA 基因 A2142G、A2143G、T2182C 和 C2195T 突变。
BMC Microbiol. 2021 Feb 3;21(1):38. doi: 10.1186/s12866-021-02096-3.

引用本文的文献

1
Antimicrobial drug susceptibility testing for the management of infection in personalized eradication therapy.用于个性化根除治疗中感染管理的抗菌药物敏感性测试。
Front Microbiol. 2025 Aug 19;16:1626930. doi: 10.3389/fmicb.2025.1626930. eCollection 2025.
2
Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.通过药敏试验和耐药分离株突变特征分析鉴定人胃内幽门螺杆菌异质性。
Sci Rep. 2024 May 27;14(1):12066. doi: 10.1038/s41598-024-62200-1.
3
Role of MIC levels and 23S rRNA mutation sites to clarithromycin in 14-day clarithromycin bismuth quadruple therapy for eradication: A prospective trial in Beijing.
14天克拉霉素铋剂四联疗法根除幽门螺杆菌治疗中,最低抑菌浓度(MIC)水平和23S rRNA基因对克拉霉素的突变位点的作用:一项在北京进行的前瞻性试验
Heliyon. 2024 Apr 17;10(8):e29774. doi: 10.1016/j.heliyon.2024.e29774. eCollection 2024 Apr 30.
4
A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination.幽门螺杆菌感染的综合研究:分子分析、抗菌药敏性和组织病理学检查。
Antonie Van Leeuwenhoek. 2023 Dec;116(12):1261-1273. doi: 10.1007/s10482-023-01868-3. Epub 2023 Aug 21.
5
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.克拉霉素耐药分离株的流行率:系统评价和荟萃分析。
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.
6
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.幽门螺杆菌克拉霉素耐药株的分子特征
Turk J Gastroenterol. 2023 Apr;34(4):427-432. doi: 10.5152/tjg.2023.21954.
7
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.幽门螺杆菌感染、实验室诊断及抗菌耐药性:临床相关性视角。
Clin Microbiol Rev. 2022 Sep 21;35(3):e0025821. doi: 10.1128/cmr.00258-21. Epub 2022 Apr 11.
8
Characterization of Domain V Mutations in Clinical Isolates of in Pakistan and Their Effect on Clarithromycin MIC.巴基斯坦临床分离株中Ⅴ结构域突变的特征及其对克拉霉素最低抑菌浓度的影响
Infect Drug Resist. 2021 Aug 24;14:3393-3403. doi: 10.2147/IDR.S306878. eCollection 2021.
9
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Infections: An Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study.克拉霉素疗效取决于克拉霉素异质性耐药感染中的细菌密度:一项基于检测药敏和定量形态计量学的回顾性研究。
Pathol Oncol Res. 2021 Jun 29;27:1609863. doi: 10.3389/pore.2021.1609863. eCollection 2021.
10
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?在土耳其成年消化不良患者中通过侵入性检测法检测幽门螺杆菌以及对包括利福平在内的六种抗生素的抗菌耐药性。克拉霉素耐药率是否在下降?
Turk J Med Sci. 2021 Jun 28;51(3):1445-1464. doi: 10.3906/sag-2101-69.